[Clinical experience on the antiflogistic and spasmolytic activity of propaxoline citrate during growth].
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002951:Citrates / Q000627:therapeutic use*; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006128:Growth; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007938:Leukemia / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D009132:Muscles / Q000627:therapeutic use*; D012516:Osteosarcoma / Q000188:drug therapy; D010069:Oxadiazoles / Q000627:therapeutic use*; D011707:Pyloric Stenosis / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy; D012512:Sarcoma, Ewing / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D002951:Citrates; D010069:Oxadiazoles
Esperienze cliniche sull'attività antiflogistica e spasmolitica della Propaxolina citrato nell'età evolutiva.